Ofev

Ofev is a medicine used to treat: - adults with idiopathic pulmonary fibrosis (IPF), a disease of unknown cause in which fibrous (scar) tissue forms in the lungs; - adults and children above the age of 6 years with systemic sclerosis-associated interstitial lung disease (ILD), a disease in which the immune system (the body’s natural defences) is overactive, causing development of fibrous tissue and progressive scarring of the lungs; - adults with other chronic interstitial lung diseases that are fibrosing (causing production of fibrous tissue) and progressive (getting worse); - children aged 6 to 17 years with clinically significant,  progressive fibrosing ILDs. Ofev contains the active substance nintedanib.